6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      “I wouldn’t need Narcan for myself, but I can have it for somebody else:” perceptions of harm reduction among hospitalized patients with OUD

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Extant literature is limited on adoption of evidence-based harm reduction strategies in hospitals. We explored patient perceptions of incorporating harm reduction supplies and education in hospital care with patients with opioid use disorder (OUD).

          Methods

          Qualitative descriptive study of hospitalized patients with OUD in Philadelphia, PA using semi-structured interviews conducted between April and August of 2022.

          Results

          Three major themes emerged from 21 interviews with hospitalized patients with OUD: (1) Applicability and Acceptability of Harm Reduction Practices for Oneself; (2) Applicability and Acceptability of Harm Reduction Practices for Others; (3) Perceptions of Harm Reduction Conversations. Most participants were familiar with harm reduction but varied in their perceptions of its relevance for their lives. We noted differences in how participants viewed the applicability and acceptably of harm reduction practices that they perceived as intended to help others (e.g., naloxone) versus intended to help themselves (e.g., syringes). Most participants reported that meaningful conversations about drug use did not happen with their care team but that these conversations would have been acceptable if they were conducted in a way consistent with their individual substance use goals.

          Conclusions

          Patients' interest and perceived acceptability of harm reduction services during hospitalization varied by individual patient factors and the perceived user of specific interventions. Given their positive potential, harm reduction practices should be incorporated in hospitals, but this must be done in a way that is acceptable to patients. Our findings reveal ways to integrate concepts from a harm reduction approach within a traditional medical model. More work is needed to understand the impact of such integration.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13722-023-00395-w.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: not found
          • Article: not found

          Qualitative research in health care. Analysing qualitative data.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

            Overdose from illicit drugs is a leading cause of premature mortality in North America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users can inject pre-obtained illicit drugs, have been opened as part of various strategies to reduce the harms associated with drug use. We sought to determine whether the opening of an SIF in Vancouver, BC, Canada, was associated with a reduction in overdose mortality. We examined population-based overdose mortality rates for the period before (Jan 1, 2001, to Sept 20, 2003) and after (Sept 21, 2003, to Dec 31, 2005) the opening of the Vancouver SIF. The location of death was determined from provincial coroner records. We compared overdose fatality rates within an a priori specified 500 m radius of the SIF and for the rest of the city. Of 290 decedents, 229 (79·0%) were male, and the median age at death was 40 years (IQR 32-48 years). A third (89, 30·7%) of deaths occurred in city blocks within 500 m of the SIF. The fatal overdose rate in this area decreased by 35·0% after the opening of the SIF, from 253·8 to 165·1 deaths per 100,000 person-years (p=0·048). By contrast, during the same period, the fatal overdose rate in the rest of the city decreased by only 9·3%, from 7·6 to 6·9 deaths per 100,000 person-years (p=0·490). There was a significant interaction of rate differences across strata (p=0·049). SIFs should be considered where injection drug use is prevalent, particularly in areas with high densities of overdose. Vancouver Coastal Health, Canadian Institutes of Health Research, and the Michael Smith Foundation for Health Research. Copyright © 2011 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Supervised injection services: what has been demonstrated? A systematic literature review.

              Supervised injection services (SISs) have been developed to promote safer drug injection practices, enhance health-related behaviors among people who inject drugs (PWID), and connect PWID with external health and social services. Nevertheless, SISs have also been accused of fostering drug use and drug trafficking.
                Bookmark

                Author and article information

                Contributors
                Rachel.french@pennmedicine.upenn.edu
                Journal
                Addict Sci Clin Pract
                Addict Sci Clin Pract
                Addiction Science & Clinical Practice
                BioMed Central (London )
                1940-0632
                1940-0640
                24 June 2023
                24 June 2023
                2023
                : 18
                : 41
                Affiliations
                [1 ]GRID grid.25879.31, ISNI 0000 0004 1936 8972, National Clinician Scholars Program, , University of Pennsylvania, ; 13th Floor Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 USA
                [2 ]GRID grid.25879.31, ISNI 0000 0004 1936 8972, Leonard Davis Institute for Health Economics, , University of Pennsylvania, ; 3641 Locust Walk, Philadelphia, PA 19104 USA
                [3 ]GRID grid.25879.31, ISNI 0000 0004 1936 8972, Perelman School of Medicine, , University of Pennsylvania, ; 423 Guardian Drive, Philadelphia, PA 19104 USA
                [4 ]GRID grid.25879.31, ISNI 0000 0004 1936 8972, School of Nursing, , University of Pennsylvania, ; 418 Curie Boulevard, Philadelphia, PA 19104 USA
                [5 ]GRID grid.25879.31, ISNI 0000 0004 1936 8972, College of Arts and Sciences, , University of Pennsylvania, ; 249 S 36th St, Philadelphia, PA 19104 USA
                [6 ]GRID grid.25879.31, ISNI 0000 0004 1936 8972, Research Director, Center for Addiction Medicine and Policy, , University of Pennsylvania, ; Philadelphia, PA USA
                Author information
                http://orcid.org/0000-0003-0379-2974
                Article
                395
                10.1186/s13722-023-00395-w
                10290347
                1102206e-fe3c-4d1e-9ced-330f50ce29eb
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 3 January 2023
                : 5 June 2023
                Funding
                Funded by: Thomas B. McCabe and Jeannette E. Laws McCabe Fund
                Funded by: FundRef http://dx.doi.org/10.13039/100000026, National Institute on Drug Abuse;
                Award ID: F32-DA053763
                Award ID: K23DA055087
                Award Recipient :
                Categories
                Research
                Custom metadata
                © Evans Medical Foundation, Inc. and BioMed Central Ltd. 2023

                Health & Social care
                opioid use disorder,substance use disorder,harm reduction,hospitalization,naloxone,fentanyl test strips,addiction,people who use drugs,patient-centered care,syringe service programs

                Comments

                Comment on this article